The Startling Drug Sales Expenses and the Medical Community's Academic Conferences
On the evening of August 27, the listed company Buchang Pharmaceutical released its 2019 semi-annual report: the company's revenue for January–June was 6.4 billion yuan, up 11.43% year on year. It is worth noting that sales expenses accounted for 3.8 billion, up 13.96% year on…
Continue reading...